Morpho Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Masaki Hiraga
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 20.6yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
We Think That There Are Issues Underlying Morpho's (TSE:3653) Earnings
Dec 21
Here's What's Concerning About Morpho's (TSE:3653) Returns On Capital
Sep 18Investors Give Morpho, Inc. (TSE:3653) Shares A 28% Hiding
Aug 05Impressive Earnings May Not Tell The Whole Story For Morpho (TSE:3653)
Jun 21We're Not Very Worried About Morpho's (TSE:3653) Cash Burn Rate
May 08Investor Optimism Abounds Morpho, Inc. (TSE:3653) But Growth Is Lacking
Feb 28CEO
Masaki Hiraga (50 yo)
20.6yrs
Tenure
Dr. Masaki Hiraga is President & Chairman of Board of Morpho, Inc. He served as President and Director at Morpho, Inc. since 2020. Dr. Hilaga graduated from the Dept. of Information Science, the School of...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chairman of Board | 20.6yrs | no data | no data | |
| Senior Director & GM of Product Development Department | 5.9yrs | no data | 0.052% ¥ 3.5m | |
| Independent Outside Director | 3.9yrs | no data | no data | |
| Audit & Supervisory Board Member | 17.9yrs | no data | 0.11% ¥ 7.8m | |
| Independent Outside Director | 7.9yrs | no data | no data | |
| Member of Audit & Supervisory Board | 6.9yrs | no data | 0.0076% ¥ 521.7k | |
| Independent Outside Director | 1.9yrs | no data | no data | |
| Audit & Supervisory Board Member | less than a year | no data | no data |
6.4yrs
Average Tenure
55.5yo
Average Age
Experienced Board: 3653's board of directors are considered experienced (6.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 11:46 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Morpho, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daisaku Masuno | Nomura Securities Co. Ltd. |